Skip to main content
TipRanks
Go Ultimate75% OFF

Therma Bright (THRM) AI Stock Analysis

65 Followers
TSE:THRM

Therma Bright

(TSXV:THRM)

Select Model
Rating:39Underperform
Price Target:CAD 0.04â–²(22.86% Upside)
Action:downgraded
Date:08/29/26

Therma Bright scores near the bottom of the range, driven primarily by severe financial weakness: negative stockholders' equity, an asset base of just ~$218K, and large losses relative to essentially no revenue, all pointing to significant going-concern and dilution risk. Technicals reinforce the caution, with the stock trading below all major moving averages and a negative MACD confirming a downtrend. Valuation provides no offset given negative earnings and no dividend. The only mitigating factors are a sharply reduced cash burn and revenue growth from a near-zero base, which are insufficient to change the highly speculative profile. Earnings call and corporate event components were excluded due to lack of data, with their weight redistributed proportionally.

Positive Factors
Revenue ReboundThe sharp revenue rebound indicates improving product demand or commercial execution. Sustaining this growth could expand operating leverage and provide a larger base from which the company can pursue breakeven.
Negative Factors
Persistent Net LossesThe large loss relative to the current revenue base shows that operating costs remain far above the company’s commercial scale. Continued losses could delay self-sufficiency and increase dependence on external capital or restructuring.

Therma Bright (THRM) vs. iShares MSCI Canada ETF (EWC)

-80%-60%-40%-20%0%20%40%TSE:THRM-46.15%EWC+13.07%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 979.95K
Dividend Yield
―
Average Volume (3M)
39.77K
Price to Earnings (P/E)
-0.5
Beta (1Y)
1.33
Revenue Growth
233.67%
EPS Growth
-3.63%
Country
Canada
Employees
5
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Therma Bright Business Overview & Revenue Model

Company Description

Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerin...

How the Company Makes Money

Therma Bright makes money primarily by selling its medical and screening products and related solutions to customers (e.g., through direct sales and distribution channels). Reported revenue is generally tied to (1) product sales (hardware such as inf...

Therma Bright Financial Statement Overview

Summary

Financials are exceptionally weak across all three statements. Revenue is negligible (~$136K TTM) against a ~$4.0M net loss, producing a net margin near -2,952% and volatile gross margins. The balance sheet has deteriorated into negative stockholders' equity (-$1.93M) with total assets of only ~$218K, raising serious going-concern risk. Cash flow remains negative (-$217K TTM operating and free cash flow), though burn has decelerated sharply from prior years. Modest positives — triple-digit revenue growth off a tiny base and reduced cash burn — are far outweighed by the near-total erosion of the asset and equity base and the likely need for dilutive financing.

Income Statement

12Very Negative

Balance Sheet

8Very Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue135.82K80.27K26.07K23.90K139.43K3,883
Gross Profit66.60K-36.93K25.46K23.90K63.48K3,883
EBITDA-3.98M-4.25M-2.34M-3.68M-5.73M-8.55M
Net Income-4.01M-4.34M-2.45M-3.77M-5.88M-8.61M
Balance Sheet
Total Assets217.95K248.69K3.19M2.21M4.00M2.24M
Cash, Cash Equivalents and Short-Term Investments25.13K38.07K1,096182.24K3.08M1.78M
Total Debt40.00K40.00K65.39K90.39K110.55K40.00K
Total Liabilities2.15M1.81M1.87M2.16M1.25M927.12K
Stockholders Equity-1.93M-1.57M1.32M44.79K2.75M1.32M
Cash Flow
Free Cash Flow-217.40K-146.53K-1.01M-2.44M-3.80M-3.16M
Operating Cash Flow-217.40K-146.53K-1.01M-2.17M-3.80M-2.86M
Investing Cash Flow00-138.26K-691.08K-204.93K-300.00K
Financing Cash Flow176.82K146.90K966.40K-33.60K5.31M3.87M

Therma Bright Technical Analysis

Technical Analysis SentimentNeutral
Last Price0.04

Price Trends

50DMA0.04Negative
100DMA0.04Negative
200DMA0.05Negative

Market Momentum

MACD-0.00Negative
RSI55.84Neutral
STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:THRM, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 55.84 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:THRM.

Therma Bright Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:THRM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:PRNTSE:PRN61NeutralCAD 349.42M-7.23-59.18%―64.70%30.61%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:PINKTSE:PINK44NeutralCAD 20.71M-1.03-303.05%―35.27%58.34%
TSE:TLTTSE:TLT41NeutralCAD 57.44M-13.03-130.04%―-24.86%18.29%
TSE:ASTITSE:ASTI40UnderperformCAD 275.99K-0.1823.95%―8.66%-545.88%
TSE:THRMTSE:THRM39UnderperformCAD 2.14M-0.51234.23%―233.67%-3.63%

* Healthcare Sector Average

Performance Comparison

0%100%200%TSE:THRMTSE:PINKTSE:PRNTSE:TLTTSE:ASTIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:THRM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:THRMTherma Bright Inc.0.04-0.03-46.15%
TSE:PINKPerimeter Medical Imaging Ai Inc0.14-0.04-25.00%
TSE:PRNProfound Medical9.541.1713.98%
TSE:TLTTheralase Technologies0.180.000.00%
TSE:ASTIAquarius Surgical Technologies 0.010.000.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 29, 2026